Projects and Grants per year
Personal profile
Education/Academic qualification
Post Doctoral Fellow, Stanford University
2019
Post Doctoral Fellow, New York Medical College
2018
Residency, New York Medical College
2015
Bachelor of Medicine, Bachelor of Surgery, Stanley Medical College
2011
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Chaitanya Iragavarapu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
26-NHL-48-MSD A Phase 2/3 Randomized, Open-label Study of MK-1045 in Combination With Rituximab in Participants With 1L Follicular Lymphoma
Iragavarapu, C. (PI)
Merck Sharp & Dohme Corporation
8/23/26 → 8/23/28
Project: Research project
-
25-NHL-45-CC (CA0731003): A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator s Choice in Participants with Relapsed/Refractory Follicular Lymphom
Iragavarapu, C. (PI)
8/28/25 → 8/28/27
Project: Research project
-
24-NHL-41-MSD (MK-2140-010-00): A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)
Iragavarapu, C. (PI)
Merck Sharp & Dohme Corporation
7/7/25 → 7/7/27
Project: Research project
-
25-NHL-43-JJ-PMC (90014496LYM1001): A Phase 1b/2 Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants with B-cell Non-Hodgkin Lymphoma
Iragavarapu, C. (PI)
Janssen Research and Development LLC
5/22/25 → 5/22/27
Project: Research project
-
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese Patients
Yalniz, F. F., Johnson, A., Alnimer, Y., Chahine, Z., Morris, T., Yadav, R., Taj, H., Iragavarapu, C., Munker, R., Monohan, G., Wai, S., Zhang, S., Nozad, S. & Qasrawi, A., Feb 2025, In: European Journal of Haematology. 114, 2, p. 365-372 8 p.Research output: Contribution to journal › Article › peer-review
-
Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma
Weng, W. K., Iragavarapu, C., Weng, G. M., Hoppe, R. T., Hiniker, S., Khodadoust, M. S. & Kim, Y. H., Jun 2024, In: Blood Neoplasia. 1, 2, 100007.Research output: Contribution to journal › Article › peer-review
Open Access -
Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience
Curry, L. D., Munker, R., Li, N., Yan, D., Pryor, P., Nozad, S., Keller, P., Monohan, G. P., Iragavarapu, C. & Krem, M. M., Jan 2023, In: Annals of Hematology. 102, 1, p. 141-154 14 p.Research output: Contribution to journal › Article › peer-review
-
AML-434 Retrospective Review of Outcomes in Newly Diagnosed Leukemia Patients Aged 65 and Older When Admitted to the Hospital: A Single Center Experience
Canter, C., Hildebrandt, G., Iragavarapu, C., Munker, R., Qasrawi, A., Ramlal, R. & Monohan, G., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S250Research output: Contribution to journal › Article › peer-review
-
Multimodality Imaging Guided Diagnosis and Treatment Response Evaluation in a Patient with Lymphoma with Right Atrioventricular Involvement
Chen, J., Ahmed, T., Ahmed, T., Iragavarapu, C., Ramlal, R. & Arbune, A., Sep 2022, In: Current Problems in Cardiology. 47, 9, 101273.Research output: Contribution to journal › Review article › peer-review